Business Description
OPKO Health is a global healthcare company founded in 2006 and based in Miami, Florida, with operations across the United States, Europe, Latin America, and Israel. The company develops a range of medical treatments, including experimental cancer-fighting antibodies, a hormone supplement for oral use, a drug designed to control blood sugar and body weight, and a long-acting growth hormone therapy for children. Through its BioReference laboratory brand, OPKO also provides a broad set of diagnostic testing services, covering areas such as genetics, women's health, cancer pathology, and disease monitoring.